3月 2026
- 首頁
- C the Signs
3月 2026C the Signs的市場佔有率分析
Discover how C the Signs integrates seamlessly with EMIS and SystmOne to help GPs detect cancer earlier, speed up referrals, and save lives through AI-powered early diagnosis.
C the Signs(包含公司地區)
查看更多網站流量與參與度資訊- cthesigns.com
C the Signs的熱門網域總造訪量
了解C the Signs市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
C the Signs的熱門網域平均造訪時長
分析C the Signs參與度指標。
過去 3 個月平均造訪時長
子公司細目
C the Signs的熱門網域平均頁面瀏覽量
了解C the Signs如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自C the Signs
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞AstraZeneca plc partners with The Signs Limited.Delivered in partnership between AstraZeneca, C the Signs, NHS Suffolk and North East Essex Integrated Care Board, Health Innovation East and GP Primary Choice, the programme represents the first time in England that population-level, AI-driven case finding has been implemented in primary care for Oesophageal and stomach cancers.
3月 19, 2026閱讀更多
新聞Khosla Ventures invested into The Signs Limited $8M in investment on Jan 4th '25.C the Signs Ltd. recently received a capital injection of $8 million from Khosla Ventures to expand its AI-powered cancer prediction platform to the U.S. market.
2月 4, 2025閱讀更多
新聞The Signs Limited receives financing of $8M in funding.C the Signs, a London, UK-based creator of an Artificial Intelligence (AI)-based platform to identify patients at risk of cancer at the earliest and most curable stage, raised $8M in funding.
1月 30, 2025閱讀更多
查看所有C the Signs信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
